Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

China Biologic Products Holdings (CBPO) gets offer from former CEO-led consortium

  • August 20, 2018


StockChina Biologic Products Holdings, Inc.SymbolCBPO
Date Announced08/17/2018Source Press Release
TypeUnsolicited BidAcquiring Company/Person former CEO-led consortium

China Biologic Products Holdings (CBPO) received a $3.9 billion all-cash offer from a consortium of investment firms led by the company’s former chief executive David Gao. The consortium, which includes GL Capital Group, Bank of China Group Investment Limited and CDH Investments, said it offered $118 per share, which represents a premium of 7.68 percent to China Biologic’s Friday closing price.


August 24, 2018: The Company announced that the Board has unanimously decided to reject the previously announced preliminary non-binding proposal from the consortium consisting of Feng Tai Global Limited, a company beneficially owned by Mr. David (Xiaoying) Gao, the former Chairman and CEO of the Company, GL Sandrose Investment L.P., World Investments Limited and CDH Utopia Limited.


Disclaimer: Our intent with this section of the website is to present potential deals that appear to be in the pipeline. These potential deals are ones where i) the company has indicated that it is "seeking strategic alternatives", ii) there has been an unsolicited bid for a company as mentioned in a press release by the company or iii) news about the deal has been published by a leading news organization like The Wall Street Journal, The New York Times, Bloomberg, Financial Times, The Washington Post, Reuters and The Associated Press. As best as possible we will try to avoid baseless rumors. There is a high probability that many of these potential deals may not materialize and if they do, the terms of the deal may be different from what was initially reported. Please do your own due diligence before buying or selling any securities mentioned on this website. We do not warrant the completeness or accuracy of the content or data provided.